Factor V Leiden Mutation in Cerebrovascular Disease
Authors:
Open Access
- 1 July 2005
- journal article
- research article
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 11 (3) , 339-342
Abstract
Several studies indicate a high prevalence of factor V Leiden mutation as the most frequent coagulation defect found in patients with venous thrombosis. The relationship between this mutation and cerebrovascular disease has not been established in adults. In this investigation, we studied 29 patients with ischemic stroke and 20 with intracerebral hemorrhage, all of whom were compared with 20 controls. A region of the factor V gene containing the Leiden mutation site was amplified with polymerase chain reaction and the presence of mutation was determined with restriction enzyme digestion. We found no evidence of an association between factor V Leiden mutation and ischemic stroke or intracerebral hemorrhage. There was no evidence of association in subgroup the analysis by age, smoking status, myocardial infarction, hypertension, diabetes mellitus, or coronary disease. Factor V Leiden mutation doesn’t seem to be associated with a risk of cerebrovascular disease.Keywords
This publication has 19 references indexed in Scilit:
- Activated Protein C Resistance and Thrombosis: Molecular Mechanisms of Hypercoagulable State Due to FVR506Q MutationSeminars in Thrombosis and Hemostasis, 1999
- CLINICAL MANIFESTATIONS IN THROMBOTIC CHILDREN WITH FACTOR V LEIDEN MUTATIONPediatric Hematology and Oncology, 1999
- Ischemic Stroke in the ElderlyStroke, 1996
- Factor V Leiden Gene Mutation and Thrombin Generation in Relation to the Development of Acute StrokeArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy MenNew England Journal of Medicine, 1995
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Resistance to Activated Protein C as a Basis for Venous ThrombosisNew England Journal of Medicine, 1994
- Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.Proceedings of the National Academy of Sciences, 1993
- The protein C anticoagulant pathway.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Congenital Protein C Deficiency and Venous ThromboembolismNew England Journal of Medicine, 1983